Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Int J Mol Sci ; 24(2)2023 Jan 06.
Article in English | MEDLINE | ID: mdl-36674653

ABSTRACT

This study aimed to examine if methanolic extracts of Pulsatilla vulgaris Mill. can inhibit HeLa cell proliferation through the modulation of cancer-related signaling pathways. The cytotoxicity and chemical composition of P. vulgaris leaves and root extracts were also determined. Research showed that root extract of P. vulgaris inhibited 12 signaling pathways in a cervical cancer cell line and the most potent activation inhibition was observed for MYC, Notch, Wnt, E2F, Ets, Stat3, Smad, Hdghog, AP-1, and NF-κB, at a concentration of 40 µg/mL. The methanolic extracts of P. vulgaris enhanced apoptotic death and deregulated cellular proliferation, differentiation, and progression toward the neoplastic phenotype by altering key signaling molecules required for cell cycle progression. This is the first study to report the influence of P. vulgaris on cancer signaling pathways. Additionally, our detailed phytochemical analysis of the methanolic extracts of P. vulgaris gives a conclusion that compounds, which strongly suppressed the growth and proliferation of HeLa cancer cells were mainly triterpenoid saponins accompanied by phenolic acids.


Subject(s)
Neoplasms , Pulsatilla , Humans , HeLa Cells , Genes, Reporter , Signal Transduction , Cell Proliferation , Plant Extracts/pharmacology , Plant Extracts/chemistry , Cell Line, Tumor , Apoptosis
2.
Sci Rep ; 11(1): 10654, 2021 05 20.
Article in English | MEDLINE | ID: mdl-34017038

ABSTRACT

The purpose of this study was to determine if a methanolic extract of the Pulsatilla patens (L.) Mill. can inhibit the progression of cancer through the modulation of cancer-related metabolic signaling pathways. We analyzed a panel of 13 inducible luciferase reporter gene vectors which expression is driven by enhancer elements that bind to specific transcription factors for the evaluation of the activity of cancer signaling pathways. The root extract of P. patens exhibited strong inhibition of several signaling pathways in HeLa cells, a cervical cancer cell line, and was found to be the most potent in inhibiting the activation of Stat3, Smad, AP-1, NF-κB, MYC, Ets, Wnt and Hdghog, at a concentration of 40 µg/mL. The methanolic extracts of P. patens enhanced apoptotic death, deregulated cellular proliferation, differentiation, and progression towards the neoplastic phenotype by altering key signaling molecules required for cell cycle progression. This is the first study to report the influence of Pulsatilla species on cancer signaling pathways. Further, our detailed phytochemical analysis of the methanolic extracts of the P. patens allowed to deduce that compounds, which strongly suppressed the growth and proliferation of HeLa cancer cells were mainly triterpenoid saponins accompanied by phenolic acids.


Subject(s)
Neoplasms/metabolism , Plant Extracts/pharmacology , Pulsatilla/chemistry , Signal Transduction , Cell Death/drug effects , Coumaric Acids/pharmacology , Genes, Reporter , HeLa Cells , Humans , Limit of Detection , Luciferases/metabolism , Methanol , Neoplasm Proteins/metabolism , Neoplasms/pathology , Plant Roots/chemistry , Reproducibility of Results , Saponins/chemistry , Saponins/pharmacology , Signal Transduction/drug effects , Triterpenes/chemistry , Triterpenes/pharmacology
3.
Food Funct ; 10(12): 8208-8217, 2019 Dec 11.
Article in English | MEDLINE | ID: mdl-31701990

ABSTRACT

Research supports the theory that the microbiome of plants and mushrooms produce potent activators of pathogen recognition receptors which are principal contributors to the stimulation of macrophages. We have previously reported that the in vitro macrophage stimulatory activity of water-soluble extracts from 13 different types of edible mushrooms is predominantly due to bacterial components originating from the naturally occurring bacterial communities within these materials. The purpose of the current study was to further investigate the bacterial-dependent activity of the water-soluble extracts and assess whether these 13 types of mushrooms contain water-insoluble beta glucans that activate the dectin-1b signaling pathway. Activity of the water-soluble extracts was predominantly due to Toll-like receptor 2 (TLR2) and TLR4 agonists. For dectin-1b-dependent activity (indicative of water-insoluble beta glucans), culinary mushrooms (Agaricus bisporus varieties) were essentially inactive, whereas most of the medicinal mushrooms (Lentinula edodes, Grifola frondosa, Hypsizygus marmoreus varieties, Flammulina velutipes) exhibited potent activation. A. bisporus samples with no detectable dectin-1b-dependent activity had yeast colony forming units that were 687 times lower than L. edodes exhibiting high activity, indicating that the active insoluble beta glucans are derived from colonizing yeast. In addition, co-stimulation of macrophages with the TLR agonists and insoluble beta glucan was found to result in a synergistic enhancement of in vitro cytokine production. Taken together, these findings indicate that the in vitro macrophage activating potential of edible mushrooms is due to the collaborative interaction of water-soluble TLR agonists (derived from colonizing bacteria) and water-insoluble beta glucans (derived from colonizing yeast).


Subject(s)
Agaricales/chemistry , Bacteria/chemistry , Lectins, C-Type/immunology , Macrophage Activation/drug effects , Macrophages/immunology , Plant Extracts/pharmacology , Toll-Like Receptors/immunology , Vegetables/microbiology , Yeasts/chemistry , beta-Glucans/pharmacology , Agaricales/classification , Animals , Bacteria/growth & development , Bacteria/metabolism , Lectins, C-Type/genetics , Macrophages/drug effects , Mice , Plant Extracts/chemistry , RAW 264.7 Cells , Toll-Like Receptors/agonists , Toll-Like Receptors/genetics , Vegetables/chemistry , Vegetables/classification , Yeasts/growth & development , Yeasts/metabolism , beta-Glucans/metabolism
4.
Sci Rep ; 9(1): 136, 2019 01 15.
Article in English | MEDLINE | ID: mdl-30644442

ABSTRACT

We previously demonstrated that extracts from Echinacea purpurea material varied substantially in their ability to activate macrophages in vitro and that this variation was due to differences in their content of bacterial components. The purpose of the current study was to identify soil conditions (organic matter, nitrogen, and moisture content) that alter the macrophage activation potential of E. purpurea and determine whether these changes in activity correspond to shifts in the plant-associated microbiome. Increased levels of soil organic matter significantly enhanced macrophage activation exhibited by the root extracts of E. purpurea (p < 0.0001). A change in soil organic matter content from 5.6% to 67.4% led to a 4.2-fold increase in the macrophage activation potential of extracts from E. purpurea. Bacterial communities also differed significantly between root materials cultivated in soils with different levels of organic matter (p < 0.001). These results indicate that the level of soil organic matter is an agricultural factor that can alter the bacterial microbiome, and thereby the activity, of E. purpurea roots. Since ingestion of bacterial preparation (e.g., probiotics) is reported to impact human health, it is likely that the medicinal value of Echinacea is influenced by cultivation conditions that alter its associated bacterial community.


Subject(s)
Echinacea/microbiology , Macrophage Activation/immunology , Microbiota/immunology , Soil/chemistry , Plant Extracts/immunology , Plant Extracts/therapeutic use , Plant Roots/immunology , Plant Roots/microbiology , Soil Microbiology
5.
Molecules ; 23(11)2018 Oct 25.
Article in English | MEDLINE | ID: mdl-30366372

ABSTRACT

Enteric septicemia of catfish, columnaris disease and streptococcosis, caused by Edwardsiella ictaluri, Flavobacterium columnare and Streptococcus iniae, respectively, are the most common bacterial diseases of economic significance to the pond-raised channel catfish Ictalurus punctatus industry. Certain management practices are used by catfish farmers to prevent large financial losses from these diseases such as the use of commercial antibiotics. In order to discover environmentally benign alternatives, using a rapid bioassay, we evaluated a crude extract from the roots of muscadine Vitis rotundifolia against these fish pathogenic bacteria and determined that the extract was most active against F. columnare. Subsequently, several isolated compounds from the root extract were isolated. Among these isolated compounds, (+)-hopeaphenol (2) and (+)-vitisin A (3) were found to be the most active (bacteriostatic activity only) against F. columnare, with 24-h 50% inhibition concentrations of 4.0 ± 0.7 and 7.7 ± 0.6 mg/L, respectively, and minimum inhibitory concentrations of 9.1 ± 0 mg/L for each compound which were approximately 25X less active than the drug control florfenicol. Efficacy testing of 2 and 3 is necessary to further evaluate the potential for these compounds to be used as antibacterial agents for managing columnaris disease.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Plant Extracts/therapeutic use , Plant Roots/chemistry , Vitis/chemistry , Animals , Anti-Bacterial Agents/chemistry , Biological Assay , Catfishes , Edwardsiella ictaluri/drug effects , Edwardsiella ictaluri/pathogenicity , Fish Diseases/drug therapy , Fish Diseases/microbiology , Flavobacterium/drug effects , Flavobacterium/pathogenicity , Microbial Sensitivity Tests , Plant Extracts/chemistry , Streptococcus iniae/drug effects , Streptococcus iniae/pathogenicity
6.
Curr Top Med Chem ; 18(3): 182-191, 2018.
Article in English | MEDLINE | ID: mdl-29332583

ABSTRACT

Enthusiasm for the use of dietary bioactive compounds as chemopreventive agents and adjuvants for current therapies has increased laboratory research conducted on several types of cancers including Head and Neck Squamous Cell Carcinoma (HNSCC). The green chemoprevention movement is a modern approach to highlight healthy lifestyle changes that aim to decrease the incidence of HNSCC. A healthy diet can be an effective way to prevent the development of oral cancers. Discovery of the naturally occurring plant based compounds called phytochemicals has facilitated the development of new treatment strategies for patients that are at risk for, or have developed HNSCC. Many of these compounds have been shown to elicit very potent anti-carcinogenic properties. While there are many compounds that have been studied, the compounds from two specific categories of phytochemicals, phenolics (resveratrol, EGCG, curcumin, quercetin, and honokiol) and glucosinolates (sulforaphane, PEITC and BITC), are emerging as potent and effective inhibitors of oral carcinogenesis. These compounds have been shown to inhibit HNSCC growth through a variety of mechanisms. Research has demonstrated that these compounds can regulate cancer cell proliferation through the regulation of multiple cell signaling pathways. They can impede cell cycle progression, induce differentiation and apoptosis, prevent angiogenesis, and inhibit cancer cell invasive and metastatic properties. They can protect normal cells during treatment and reduce the damage caused by chemotherapy and radiotherapy. This review aims to provide an overview of some of the most effective phytochemicals that have the potential to successfully prevent and treat head and neck squamous cell carcinoma.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/prevention & control , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/prevention & control , Phytochemicals/pharmacology , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Carcinoma, Squamous Cell/pathology , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor , Head and Neck Neoplasms/pathology , Humans , Phytochemicals/chemistry , Structure-Activity Relationship
7.
Food Funct ; 7(10): 4213-4221, 2016 Oct 12.
Article in English | MEDLINE | ID: mdl-27711863

ABSTRACT

Recent studies have indicated that a major contributor to the innate immune enhancing properties of some medicinal plants is derived from the cell wall components of bacteria colonizing these plants. The purpose of the current study was to assess if the bacteria present within edible and medicinal mushrooms substantially contribute to the innate immune stimulating potential of these mushrooms. Whole mushrooms from thirteen types of edible fungi and individual parts from Agaricus bisporus were analyzed for in vitro macrophage activation as well as bacterial lipopolysaccharides (LPS) content, cell load, and community composition. Substantial variation between samples was observed in macrophage activation (over 500-fold), total bacterial load (over 200-fold), and LPS content (over 10 million-fold). Both LPS content (ρ = 0.832, p < 0.0001) and total bacterial load (ρ = 0.701, p < 0.0001) correlated significantly with macrophage activation in the whole mushroom extracts. Extract activity was negated by treatment with NaOH, conditions that inactivate LPS and other bacterial components. Significant correlations between macrophage activation and total bacterial load (ρ = 0.723, p = 0.0001) and LPS content (ρ = 0.951, p < 0.0001) were also observed between different tissues of Agaricus bisporus. Pseudomonas and Flavobacterium were the most prevalent genera identified in the different tissue parts and these taxa were significantly correlated with in vitro macrophage activation (ρ = 0.697, p < 0.0001 and ρ = 0.659, p = 0.0001, respectively). These results indicate that components derived from mushroom associated bacteria contribute substantially to the innate immune enhancing activity exhibited by mushrooms and may result in similar therapeutic actions as reported for ingestion of bacterial preparations such as probiotics.


Subject(s)
Agaricales/chemistry , Bacteria/chemistry , Complex Mixtures/chemistry , Macrophages/drug effects , Animals , Bacteria/genetics , Mice , RAW 264.7 Cells , RNA, Ribosomal, 16S/genetics
8.
Planta Med ; 82(14): 1258-65, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27286330

ABSTRACT

Evidence supports the theory that bacterial communities colonizing Echinacea purpurea contribute to the innate immune enhancing activity of this botanical. Previously, we reported that only about half of the variation in in vitro monocyte stimulating activity exhibited by E. purpurea extracts could be accounted for by total bacterial load within the plant material. In the current study, we test the hypothesis that the type of bacteria, in addition to bacterial load, is necessary to fully account for extract activity. Bacterial community composition within commercial and freshly harvested (wild and cultivated) E. purpurea aerial samples was determined using high-throughput 16S rRNA gene pyrosequencing. Bacterial isolates representing 38 different taxa identified to be present within E. purpurea were acquired, and the activity exhibited by the extracts of these isolates varied by over 8000-fold. Members of the Proteobacteria exhibited the highest potency for in vitro macrophage activation and were the most predominant taxa. Furthermore, the mean activity exhibited by the Echinacea extracts could be solely accounted for by the activities and prevalence of Proteobacteria members comprising the plant-associated bacterial community. The efficacy of E. purpurea material for use against respiratory infections may be determined by the Proteobacterial community composition of this plant, since ingestion of bacteria (probiotics) is reported to have a protective effect against this health condition.


Subject(s)
Echinacea/microbiology , Macrophage Activation , Plant Extracts/immunology , Proteobacteria/immunology , Animals , Echinacea/immunology , Mice , RAW 264.7 Cells
9.
Phytomedicine ; 22(2): 271-6, 2015 Feb 15.
Article in English | MEDLINE | ID: mdl-25765832

ABSTRACT

A growing body of research indicates that oral administration of bacteria (such as probiotics) can exhibit a protective effect against influenza A (H1N1) viral infection in mice. In the present study, we used a mouse model to examine whether oral administration of Immulina(®), a commercial extract from the cyanobacteria Arthrospira (Spirulina) platensis, can reduce the severity of illness resulting from influenza A (H1N1) viral infection. The main active compounds within Immulina(®) are bacterial Braun-type lipoproteins that activate innate immune cells through a toll-like receptor (TLR) 2-dependent pathway. Mice that were fed Immulina(®) for 30 days before and 21 days after infection with influenza A (H1N1) virus exhibited a statistically significant reduction in the severity of infection. Compared to the control group, Immulina(®)-fed mice exhibited less weight loss, increased appetite, decreased clinical signs of disease, and lower lung histopathology scores. The results from the present study adds to the increasing evidence that oral administration of bacterial components that activate innate immune cells, whether derived from a bacterial preparation (probiotics or cyanobacteria) or from plant material containing endophytic bacteria, can exhibit a protective effect against influenza A (H1N1) viral infection.


Subject(s)
Dietary Supplements , Orthomyxoviridae Infections/drug therapy , Polysaccharides, Bacterial/pharmacology , Spirulina/chemistry , Administration, Oral , Animals , Cell Line , Disease Models, Animal , Female , Influenza A Virus, H1N1 Subtype , Lung/pathology , Macrophages/drug effects , Mice, Inbred BALB C
10.
Planta Med ; 79(1): 9-14, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23212786

ABSTRACT

Our previous studies indicate that the majority of in vitro monocyte/macrophage activation exhibited by extracts of Echinacea depends on bacterial components. In the present study, total bacterial load was determined within E. purpurea samples and ranged from 6.4 × 10(6) to 3.3 × 10(8) bacteria/g of dry plant material. To estimate total bacterial load, we developed a PCR-based quantification method that circumvents the problems associated with nonviable/nonculturable cells (which precludes using plate counts) or the coamplification of mitochondrial or chloroplast DNA with the use of universal bacterial primers (which precludes the use of qPCR). Differences in total bacterial load within Echinacea samples were strongly correlated with the activity (NF-κB activation in THP-1 cells) and content of bacterial lipopolysaccharides within extracts of this plant material. These results add to the growing body of evidence that bacteria within Echinacea are the main source of components responsible for enhancing innate immune function.


Subject(s)
Bacteria/isolation & purification , Bacterial Load , Echinacea/microbiology , Lipopolysaccharides/analysis , Lipopolysaccharides/pharmacology , Macrophages/immunology , Plant Extracts/chemistry , Cell Line , Humans , Macrophage Activation/drug effects , Macrophage Activation/immunology , NF-kappa B/metabolism , Plant Components, Aerial/microbiology , Plant Roots/microbiology , Polymerase Chain Reaction
11.
Planta Med ; 76(16): 1802-8, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20560112

ABSTRACT

Immulina®, a commercial extract of Arthrospira (Spirulina) platensis is a potent activator of THP-1 monocytes and CD4+ T cells IN VITRO and enhances several immunological functions in mice. We further characterized Immulina® by determining that Braun-type lipoproteins are responsible for a major portion of the IN VITRO monocyte activation exhibited by this material. In order to understand the effect of Immulina® on NK cell activity, a pilot study was conducted on ten healthy North American individuals who supplemented their diet with Immulina® (400 mg/day) for seven days. We observed a 40% average increase in the killing of K562 tumor cells by NK cells (p < 0.01) after Immulina® supplementation. In a separate placebo-controlled, crossover study involving 11 healthy Danish subjects, we observed increased mRNA expression of the NK cell marker NKG2D by 37% (p = 0.02) and by 55% (p = 0.0003) after administration of Immulina® (200 mg and 400 mg per day, respectively) for seven days. The mRNA expression of the NK- and T-cell marker perforin increased by 75% (p = 0.008) after administration of 400 mg Immulina® per day. Both markers displayed significant dose-dependent effects (p = 0.0003 and p = 0.02, respectively). The ratio between CD56 (bright) and CD56 (dim) NK cells was not affected by Immulina® administration. In summary, two independent studies showed enhancement of NK cell activity following administration of Immulina® for seven days.


Subject(s)
Adjuvants, Immunologic/pharmacology , Killer Cells, Natural/drug effects , Leukemia, Erythroblastic, Acute/drug therapy , Lipoproteins/pharmacology , Lymphocyte Activation/drug effects , Plant Extracts/pharmacology , Spirulina/chemistry , Adjuvants, Immunologic/therapeutic use , Adult , Aged , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/therapeutic use , Biomarkers/metabolism , Cell Line, Tumor , Cross-Over Studies , Dietary Supplements , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Leukocytes, Mononuclear/drug effects , Lipoproteins/therapeutic use , Male , Middle Aged , NK Cell Lectin-Like Receptor Subfamily K/genetics , NK Cell Lectin-Like Receptor Subfamily K/metabolism , Perforin/genetics , Perforin/metabolism , Phytotherapy , Pilot Projects , Plant Extracts/therapeutic use , RNA, Messenger/metabolism , Reference Values , T-Lymphocytes , Young Adult
12.
J Agric Food Chem ; 56(22): 10552-6, 2008 Nov 26.
Article in English | MEDLINE | ID: mdl-18942831

ABSTRACT

We previously reported that the majority of in vitro monocyte/macrophage activation exhibited by extracts of Echinacea and other botanicals depends upon bacterial lipopolysaccharides and Braun-type bacterial lipoproteins. We determined the contribution made by these bacterial components to the overall immune-enhancing activity detected in E. purpurea and E. angustifolia bulk root and aerial material obtained from six major growers/suppliers in North America. Substantial variation in activity (up to 200-fold) was observed in extracts of these materials when tested in two monocyte/macrophage cell lines. The majority of activity was negated by treatment with agents that target bacterial lipoproteins (lipoprotein lipase) and lipopolysaccharides (polymyxin B). Experiments comparing the activity of freeze-dried, freshly harvested Echinacea plants to those harvested and dried using various commercially relevant conditions suggest that postharvesting procedures do not substantially contribute to the variation observed in the commercial material.


Subject(s)
Bacteria/chemistry , Echinacea/chemistry , Lipopolysaccharides/pharmacology , Lipoproteins/pharmacology , Macrophage Activation/drug effects , Plant Extracts/pharmacology , Desiccation/methods , Escherichia coli/chemistry , Plant Leaves/chemistry , Plant Roots/chemistry
13.
Int Immunopharmacol ; 8(7): 1023-32, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18486914

ABSTRACT

We have identified potent monocyte/macrophage activating bacterial lipoproteins within commonly used immune enhancing botanicals such as Echinacea, American ginseng and alfalfa sprouts. These bacterial lipoproteins, along with lipopolysaccharides, were substantially more potent than other bacterially derived components when tested in in vitro monocyte/macrophage activation systems. In experiments using RAW 264.7 and mouse peritoneal macrophages the majority (85-98%) of the activity within extracts from eight immune enhancing botanicals was eradicated by treatment with agents (lipoprotein lipase and polymyxin B) known to target these two bacterial components. Alfalfa sprouts exhibited the highest activity of those botanicals tested but the appearance of this activity during the germination of surface sterilized seeds was abolished by the presence of antibiotics. These studies indicate that the majority of the in vitro macrophage activating properties in extracts from these botanicals can be attributed to the presence of lipoproteins and lipopolysaccharides derived from bacteria and that bacterial endophytes may be a significant source of these components.


Subject(s)
Adjuvants, Immunologic/pharmacology , Bacterial Proteins/pharmacology , Lipopolysaccharides/pharmacology , Lipoproteins/pharmacology , Macrophage Activation/drug effects , Plant Extracts/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Echinacea , Male , Medicago sativa , Melanins/pharmacology , Mice , Mice, Inbred C57BL , Panax , Toll-Like Receptor 2/physiology
14.
Phytother Res ; 21(8): 741-5, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17450505

ABSTRACT

Pimpinella essential oils and isolated compounds were screened for their inhibitory activity against NF-kappaB mediated transcription in SW1353 cells. Twelve oils were effective in inhibiting NF-kappaB mediated transcription. Especially the roots of P. corymbosa, P. tragium and P. rhodanta showed potent activities with IC(50) values of 2, 3 and 6 microg/mL, respectively. Five pure compounds, 7 (4-(2-propenyl)phenylangelate), 12 (4-(3-methyloxiranyl)phenyltiglate), 17 (4-methoxy-2-(3-methyloxiranyl)phenyl isobutyrate), 18 (4-methoxy-2-(3-methyloxiranyl)phenylangelate) and 21 (epoxy pseudoisoeugenol-2-methylbutyrate) inhibited NF-kappaB mediated transcription with IC(50) values of 5.5, 1.2, 0.01, 3.6 and 11 microg/mL, respectively. None of the compounds were cytotoxic to mammalian cells. These findings add significant information to the pharmacological activity of Pimpinella species and their beneficial effects and use in disease prevention especially those related to inflammation.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , NF-kappa B/antagonists & inhibitors , Oils, Volatile/pharmacology , Pimpinella/chemistry , Plant Oils/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Cell Line , Chlorocebus aethiops , Gene Expression Regulation/drug effects , Humans , Molecular Structure , Oils, Volatile/chemistry , Phytotherapy , Plant Components, Aerial/chemistry , Plant Oils/chemistry , Plant Roots/chemistry , Species Specificity
15.
Cancer Chemother Pharmacol ; 60(1): 35-43, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17149609

ABSTRACT

PURPOSE: Nuclear factor-kappaB (NF-kappaB) plays a crucial role in the regulation of inflammatory processes, cell proliferation, and apoptosis. Blocking NF-kappaB signaling may represent a therapeutic strategy in cancer and inflammation therapy. The aim of this study was to investigate the effects of sesquiterpenes isolated from Asteraceae, namely melampolides (enhydrin, tetraludin A) and repandolides (repandins A, B, D and E) on the activation of NF-kappaB, cell growth of cancer cells, cell cycle progression and apoptosis. In addition, their effects on the activity of cyclooxygenase-2 (COX-2) enzyme were also evaluated. METHODS: Cell-based reporter gene assay was conducted in SW1353 cells. COX-2 enzyme activity and cell growth inhibition was determined by enzyme immunoassay and MTT assay respectively. Cell cycle analysis was carried out by flow cytometry and apoptosis was observed by DAPI staining assay. RESULTS: In SW1353 cells, transcription mediated by NF-kappaB was inhibited by enhydrin, tetraludin A and repandins A, B, D and E, while Sp-1 mediated transcription was not affected. COX-2 enzyme activity was inhibited by enhydrin, repandin A and E, but not by tetraludin A, repandin B and D. These compounds were effective in inhibiting the growth of a panel of human tumor cell lines in a concentration-dependent manner. Cell cycle analysis and DAPI staining indicated cell cycle arrest in G(2)/M phase and induction of apoptosis. CONCLUSIONS: Enhydrin, tetraludin A and repandins A, B, D and E inhibited tumor cell growth and induced cell cycle arrest and apoptosis. These effects may be related to inhibition of NF-B activation.


Subject(s)
Apoptosis/drug effects , NF-kappa B/antagonists & inhibitors , Sesquiterpenes/pharmacology , Transcription, Genetic/drug effects , Asteraceae/chemistry , Cell Cycle/drug effects , Cell Line , Cell Line, Tumor , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/chemistry , Cyclooxygenase 2 Inhibitors/isolation & purification , Cyclooxygenase 2 Inhibitors/pharmacology , Dose-Response Relationship, Drug , G2 Phase/drug effects , HL-60 Cells , Humans , Inhibitory Concentration 50 , Lactones/chemistry , Lactones/isolation & purification , Lactones/pharmacology , Luciferases/genetics , Luciferases/metabolism , Macrophages/drug effects , Macrophages/metabolism , Microscopy, Fluorescence , Molecular Structure , NF-kappa B/genetics , NF-kappa B/metabolism , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Sesquiterpenes/chemistry , Sesquiterpenes/isolation & purification , Sp1 Transcription Factor/metabolism , Tetradecanoylphorbol Acetate/pharmacology
16.
Int Immunopharmacol ; 6(12): 1808-14, 2006 Dec 05.
Article in English | MEDLINE | ID: mdl-17052671

ABSTRACT

We reported previously that a high molecular weight polysaccharide fraction (Immulina) from Spirulina was a potent activator of NF-kappa B and induced both IL-1 beta and TNF-alpha mRNAs in THP-1 human monocytes. In the present study, we show that NF-kappa B activation by Immulina is suppressed by antibodies to CD14 and TLR2 but not by antibodies to TLR4. Similarly, NF-kappa B directed luciferase expression was enhanced by Immulina treatment when cells were co-transfected with vectors expressing proteins supporting TLR2- (CD14 and TLR2) but not TLR4-(CD14, TLR4, and MD-2) dependent activation. Mice that consumed a chemically defined chow mixed with an extract containing Immulina exhibited changes in several immune parameters. The ex vivo production of IgA and IL-6 from Peyer's patch cells was enhanced 2-fold and interferon-gamma production from spleen cells was increased 4-fold in Immulina-treated mice. The enhanced production of these factors was most notable with mice that had consumed this extract for 4 or 5 days. These studies shed light on how Immulina activates cells of the innate immune system and suggests that oral consumption of this polysaccharide can enhance components within both the mucosal and systemic immune systems.


Subject(s)
Monocytes/drug effects , Polysaccharides/pharmacology , Spirulina/chemistry , Toll-Like Receptor 2/immunology , Animals , Cell Line , Humans , Immunoglobulin A/immunology , Interferon-gamma/immunology , Interleukin-6/immunology , Lipopolysaccharide Receptors/immunology , Mice , Monocytes/immunology , NF-kappa B/immunology , Peyer's Patches/cytology , Peyer's Patches/immunology , Plant Extracts/chemistry , Polysaccharides/isolation & purification , Polysaccharides, Bacterial , Spleen/cytology , Spleen/immunology
17.
Kidney Int ; 67(5): 1797-805, 2005 May.
Article in English | MEDLINE | ID: mdl-15840026

ABSTRACT

BACKGROUND: Aristolochia species are nephrotoxic and carcinogenic. Recent studies showed that aristolochic acid (AA) could induce acute renal failure and tubular lesions in several species and available evidences demonstrate the unequivocal role of AA in so called Chinese herbs nephropathy. METHODS: A series of AA derivatives isolated from Aristolochia spp. were analyzed for their nephrotoxic potential using the neutral red dye exclusion assay in cultures of LLC-PK(1) cells. The structural relationships between AA I and its analogues were compared with their cytotoxic effects to predict structural determinants for AA toxicity. Further, caspase-3 assay was performed on toxic compounds to determine if caspases, the enzymes that play a critical role in apoptosis are involved in AA-induced cytotoxicity. RESULTS: AA I was found to be most toxic followed by AA II, AA VIIIa, and AA Ia in decreasing levels of toxicity. The other compounds, nitrophenanthrene carboxylic acid analogues of AA I, aristolactams, and other derivatives did not exhibit considerable toxicity. The results showed significant relationships between cytotoxicity of AA compounds and the localization of functional groups in their structure. Analogues containing hydroxyl groups diminished cytotoxicity. The demethylated analogues of AA I are markedly less active. The negative impact on cytotoxicity was found on nitroreduction of AA I. AA induced caspase activation was also observed. CONCLUSION: These cytotoxic data suggest that the nitro and methoxy groups are critical determinants of nephrotoxicologic potency of AA.


Subject(s)
Aristolochic Acids/chemistry , Aristolochic Acids/toxicity , Kidney/drug effects , Animals , Apoptosis/drug effects , Caspase 3 , Caspase 7 , Caspases/metabolism , Cell Line , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/toxicity , Enzyme Activation/drug effects , Epithelial Cells/drug effects , Epithelial Cells/enzymology , Epithelial Cells/pathology , Kidney/enzymology , Kidney/pathology , LLC-PK1 Cells , Nephritis, Interstitial/chemically induced , Nephritis, Interstitial/enzymology , Nephritis, Interstitial/pathology , Structure-Activity Relationship , Swine
18.
Int Immunopharmacol ; 5(4): 637-47, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15710333

ABSTRACT

The agents responsible for the therapeutic effects of many botanical supplements have not been established in spite of their popularity. Here we show that melanin is a previously unrecognized immunostimulatory compound that is a major component of botanicals traditionally used to enhance immune function. While melanin is present in commonly consumed vegetables, its specific activity is several orders of magnitude less than melanin extracted from these botanicals. The major reason that this agent has eluded detection is its solvent-specific requirement for extraction/solubility. Melanin activates NF-kappa B in monocytes in vitro through a toll-like receptor 2-dependent process. Ingestion of melanin by mice for four days increases production ex vivo of interferon-gamma by spleen cells and IgA and interleukin-6 by Peyer's patch cells. The identification of this new class of mucosal immune stimulants will allow further characterization of botanical products and advances our understanding of the basis for their traditional use.


Subject(s)
Echinacea/chemistry , Immunity, Mucosal/drug effects , Melanins/pharmacology , Animals , Cell Line , Cytokines/metabolism , Dietary Supplements , Dose-Response Relationship, Drug , Humans , Male , Melanins/isolation & purification , Membrane Glycoproteins/physiology , Mice , Mice, Inbred C3H , Monocytes/drug effects , NF-kappa B/physiology , Receptors, Cell Surface/physiology , Spleen/drug effects , Spleen/metabolism , Toll-Like Receptor 2 , Toll-Like Receptors
19.
J Nat Prod ; 65(7): 979-85, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12141856

ABSTRACT

Activity-guided fractionation of an ethanol extract of Lycopodium cernuum for Candida albicans secreted aspartic proteases (SAP) inhibition resulted in the identification of six new (1-6) and four known (7-10) serratene triterpenes, along with the known apigenin-4'-O-(2' ',6' '-di-O-p-coumaroyl)-beta-D-glucopyranoside (11). On the basis of spectroscopic analysis, the structures of 1-10 were established as 3beta,14alpha,15alpha,21beta,29-pentahydroxyserratane-24-oic acid (lycernuic acid C, 1), 3beta,14alpha,15alpha,21beta-tetrahydroxyserratane-24-oic acid (lycernuic acid D, 2), 3beta,14beta,21beta-trihydroxyserratane-24-oic acid (lycernuic acid E, 3), 3beta,21beta,29-trihydroxy-16-oxoserrat-14-en-24-methyl ester (lycernuic ketone A, 4), 3alpha,21beta,29-trihydroxy-16-oxoserrat-14-en-24-methyl ester (lycernuic ketone B, 5), 3alpha,21beta,24-trihydroxyserrat-14-en-16-one (lycernuic ketone C, 6), 3beta,21beta-dihydroxyserrat-14-en-24-oic acid (lycernuic acid A, 7), 3beta,21beta,29-trihydroxyserrat-14-en-24-oic acid (lycernuic acid B, 8), serrat-14-en-3beta,21beta-diol (9), and serrat-14-en-3beta,21alpha-diol (10). The 13C NMR data for the known compounds 7 and 8 are reported for the first time. Compounds 1 and 11 showed inhibitory effects against C. albicans secreted aspartic proteases (SAP) with IC50 of 20 and 8.5 microg/mL, respectively, while the other compounds were inactive.


Subject(s)
Antifungal Agents/isolation & purification , Aspartic Acid Endopeptidases/antagonists & inhibitors , Candida albicans/drug effects , Enzyme Inhibitors/isolation & purification , Lycopodiaceae/chemistry , Plants, Medicinal/chemistry , Protease Inhibitors/isolation & purification , Triterpenes/isolation & purification , Acetylation , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Chromatography, High Pressure Liquid , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Hydrolysis , Inhibitory Concentration 50 , Molecular Conformation , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Peru , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacology , Spectroscopy, Fourier Transform Infrared , Structure-Activity Relationship , Triterpenes/chemistry , Triterpenes/pharmacology
20.
J Nat Prod ; 65(6): 856-9, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12088427

ABSTRACT

A phytochemical investigation of the CHCl(3) fraction of an ethanol extract of the root of Guatteria multivenia furnished nine compounds, of which four are sesquiterpenes (1-4) and five are alkaloids (5-9). Of the four sesquiterpenes, two are new (1, 3), named guatterin A (1) and dihydromadolin-K (3), and two are known (2, 4), identified as madolin-K (2) and madolin-W (4). The five known alkaloids were identified as liriodenine (5), lysicamine (6), lanuginosine (7), guadiscine (8), and O-methylpallidine (9). All the known compounds were isolated from this species for the first time. Structures of the new compounds were determined by extensive NMR studies, including DEPT, COSY, HMQC, HMBC, and NOESY. Compound 7 showed weak inhibitory effect against Candida albicans secreted aspartic proteases (SAP) with IC(50) of 45 microg/mL. Compound 5 was found to have antimicrobial activity against C. albicans, Cryptococcusneoformans, Staphylococcus aureus, and methicillin-resistant S. aureus (MRS) with IC(50)/MIC values of 3.5/6.25, 2.0/12.5, 2.0/3.13, and 2.0/3.13 microg/mL, respectively.


Subject(s)
Alkaloids/isolation & purification , Annonaceae/chemistry , Anti-Infective Agents/isolation & purification , Plants, Medicinal/chemistry , Protease Inhibitors/isolation & purification , Sesquiterpenes/isolation & purification , Alkaloids/chemistry , Alkaloids/pharmacology , Anti-Bacterial Agents , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Aporphines/pharmacology , Aspartic Acid Endopeptidases/antagonists & inhibitors , Candida albicans/drug effects , Cryptococcus neoformans/drug effects , Inhibitory Concentration 50 , Molecular Conformation , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Peru , Plant Roots/chemistry , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacology , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , Staphylococcus aureus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL